Published in Am J Transl Res on July 15, 2017
Cancer statistics, 2016. CA Cancer J Clin (2016) 32.95
Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer. Cancer Cell (2013) 2.55
Prostate cancer. Lancet (2015) 1.58
Asf1b, the necessary Asf1 isoform for proliferation, is predictive of outcome in breast cancer. EMBO J (2010) 1.25
BRAT1 deficiency causes increased glucose metabolism and mitochondrial malfunction. BMC Cancer (2014) 0.99
Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of P53 and inhibition of DNA replication. Haematologica (2012) 0.97
Mutations in the isocitrate dehydrogenase genes IDH1 and IDH2 in tumors. Adv Anat Pathol (2013) 0.95
Epigenetic modifiers enhance the synergistic cytotoxicity of combined nucleoside analog-DNA alkylating agents in lymphoma cell lines. Exp Hematol (2012) 0.92
Mutations of the metabolic genes IDH1, IDH2, and SDHAF2 are not major determinants of the pseudohypoxic phenotype of sporadic pheochromocytomas and paragangliomas. J Clin Endocrinol Metab (2010) 0.91
Histone chaperone ASF1B promotes human β-cell proliferation via recruitment of histone H3.3. Cell Cycle (2016) 0.86
Expert opinion on first-line therapy in the treatment of castration-resistant prostate cancer. Crit Rev Oncol Hematol (2015) 0.86
The control of DNA repair by the cell cycle. Nat Cell Biol (2016) 0.86
Cycling through developmental decisions: how cell cycle dynamics control pluripotency, differentiation and reprogramming. Development (2016) 0.84
Tumour escape mechanisms and their therapeutic implications in combination tumour therapy. Cell Biol Int (2010) 0.84
"Combi-targeting" mitozolomide: conferring novel signaling inhibitory properties to an abandoned DNA alkylating agent in the treatment of advanced prostate cancer. Prostate (2012) 0.82
Castration-Resistant Prostate Cancer: AUA Guideline Amendment 2015. J Urol (2015) 0.81
New anti-cancer molecules targeting HSPA5/BIP to induce endoplasmic reticulum stress, autophagy and apoptosis. Autophagy (2016) 0.81
Tim/Timeless, a member of the replication fork protection complex, operates with the Warsaw breakage syndrome DNA helicase DDX11 in the same fork recovery pathway. Nucleic Acids Res (2015) 0.81
Global iTRAQ-based proteomic profiling of Toxoplasma gondii oocysts during sporulation. J Proteomics (2016) 0.80
Co-targeting hexokinase 2-mediated Warburg effect and ULK1-dependent autophagy suppresses tumor growth of PTEN- and TP53-deficiency-driven castration-resistant prostate cancer. EBioMedicine (2016) 0.79
A timeless but timely connection between replication and recombination. Cell (2014) 0.79
Targeting hexokinase 2 in castration-resistant prostate cancer. Mol Cell Oncol (2015) 0.78
Biological effects of novel "combi-targeting" molecule and its effect on DNA repair pathway in hormone-refractory prostate cancer. Am J Cancer Res (2015) 0.77
Glycoconjugated Site-Selective DNA-Methylating Agent Targeting Glucose Transporters on Glioma Cells. Biochemistry (2017) 0.77
Decreased Usage of Specific Scrib Exons Defines a More Malignant Phenotype of Breast Cancer With Worsened Survival. EBioMedicine (2016) 0.77
Nedd4 family interacting protein 1 (Ndfip1) is required for ubiquitination and nuclear trafficking of BRCA1-associated ATM activator 1 (BRAT1) during the DNA damage response. J Biol Chem (2015) 0.77